Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Environ Sci Technol ; 40(20): 6460-5, 2006 Oct 15.
Article in English | MEDLINE | ID: mdl-17120581

ABSTRACT

This paper addresses the change of molecular size distribution of humic substances (HS) during ozonation in a membrane contactor. It focuses on the characterization and identification of some small ozonation products. The membrane contactor setup allows very precise control of ozone transfer into the solution as well as precise sampling of the products in time. The molecular size distribution was followed by gel permeation chromatography (GPC). Characterization and identification of small ozonation products was performed by membrane nanofiltration and high-performance liquid chromatography (HPLC). Measurements on molecular size distribution indicate that during the ozonation process the size of the HS molecules decreases slowly and only small highly oxidated compounds are being split off the larger molecules. Pyruvic acid, formic acid, methylglyoxal, and acetaldehyde could be identified by substantial peaks. Glyoxilic acid and glyoxal were identified to a lesser extent. This suggests that HS molecules consist of a relatively stable backbone network structure and that the HS molecule degrades according to an outside-in trimming mechanism.


Subject(s)
Humic Substances/analysis , Ozone/chemistry , Acetaldehyde/analysis , Chromatography, Gas , Chromatography, High Pressure Liquid , Formates/analysis , Hydrogen-Ion Concentration , Models, Chemical , Pyruvaldehyde/analysis , Pyruvic Acid/analysis
2.
Arch Orthop Trauma Surg ; 120(1-2): 48-52, 2000.
Article in English | MEDLINE | ID: mdl-10653104

ABSTRACT

In 86 patients 102 consecutive cemented Kinematic total knee arthroplasties were reviewed 10-15 years after surgery to determine the clinical and radiographic results and to assess the survival rate. The average age of the 65 female and 21 male patients at the time of surgery was 63 years. Forty-six knees were affected by rheumatoid arthritis (RA), 46 by osteoarthritis (OA), 7 by haemophilic arthropathy and 3 by osteonecrosis. One patient (1 knee) was lost to follow-up, and 31 patients (38 knees) died. Eleven knees had been revised for deep infection (4), wear (4), malposition (2) or persistent pain (1). Fifty-two knees were examined at an average follow-up period of 12 years. The mean Knee Society Score of 89 points was the same for RA and AO knees. Also, 92% of the knees caused no pain or only occasional mild pain. There were no cases of aseptic loosening of any component. Progressive radiolucent lines were not seen on the follow-up radiographs (43 knees, mean follow-up 12 years) The 10- and 14-year survival rates with revision as the end-point were 90% (confidence interval, CI: 81%-95%) and 82% (CI: 67%-92%), respectively. In the worst case scenario, with knees lost to follow-up and knees with moderate pain considered as failures, the 10- and 14-year survival rates were 80% (CI: 69%-88%) and 62% (CI: 46%-77%), respectively. The Kinematic total knee arthroplasty yields equally good long-term results in patients with RA and those with OA. Deep infection and wear were the main reasons for revision.


Subject(s)
Arthritis, Rheumatoid/surgery , Arthroplasty, Replacement, Knee , Osteoarthritis, Knee/surgery , Adult , Aged , Aged, 80 and over , Female , Humans , Life Tables , Male , Middle Aged , Reoperation , Survival Analysis
3.
Ann Oncol ; 9(1): 109-11, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9541692

ABSTRACT

BACKGROUND: CD44 is an adhesion molecule and represents a highly variable family of isoforms. The isoform CD44v6 has been associated with metastasis formation and poor prognosis in animal models and human colon cancer. Results of studies in primary breast cancer are relatively small and contradictory. PATIENTS AND METHODS: The immunohistochemical expression of CD44v6 was studied in a series of 338 patients with primary breast tumours, uniformly staged and treated in a single center with a long median follow-up of 128 months. The prognostic significance of CD44v6 as well as the correlation with several clinicopathological features were analysed. RESULTS: Two hundred nineteen of 338 (64.8%) of the breast cancer were CD44v6-positive (> 5% of tumour cells with positive staining). CD44v6 expression had no value for prognosticating disease-free or overall survival at this or any other cut-off point. CONCLUSION: CD44v6 expression is not a prognostic factor in primary breast cancer.


Subject(s)
Biomarkers, Tumor , Breast Neoplasms/immunology , Hyaluronan Receptors/analysis , Adult , Aged , Aged, 80 and over , Disease-Free Survival , Female , Follow-Up Studies , Humans , Middle Aged , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL